Skip to main content
Log in

Tenofovir DF: increased risk of kidney tubular dysfunction

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. β2-microglobulinuria; fractional excretion of phosphate; fractional excretion of uric acid; N-acetyl-β-D-glucosaminidase; non-diabetic glycosuria

Reference

  • Nishijima T, et al. Cumulative exposure of tenofovir disoproxil fumarate is associated with kidney tubulopathy whether it is currently used or discontinued in HIV-infected patients. AIDS : 12 Oct 2017. Available from: URL: http://doi.org/10.1097/QAD.0000000000001667

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tenofovir DF: increased risk of kidney tubular dysfunction. Reactions Weekly 1675, 13 (2017). https://doi.org/10.1007/s40278-017-37781-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-37781-8

Navigation